1593385-A1 cites 14 patents.

Biologically active substance (I), preferably for early diagnosis and/or preventive therapy of virus-infected living cells, comprises at least one component of histone, covalent modified histone, similar histone polypeptide, biologically active sequences of the histone and similar histone peptide. - Biologically active substance (I), preferably for early diagnosis and/or preventive therapy of virus-infected living cells, (where the effectiveness of (I) is selective against the cell membranes of the virus infected cells that after the virus attack are modified or degenerated) comprises at least one component of histone, covalent modified histone, similar histone polypeptide, biologically active sequences of the histone and similar histone peptide.; - An INDEPENDENT CLAIM is also included for a biochip for diagnosis of virus-infected cells comprising a selected number of different biologically active agents respectively with a biological activity on the organic chip that serves for determining an individual's profile of the disease, where the active agents are histones, covalently modified histone, similar histone polypeptides, biologically active sequences of the histone or similar histone peptides. - ACTIVITY - Virucide. - MECHANISM OF ACTION - None given.

Title
Use of histones for the early diagnosis and/or preventive therapy of virus-infected living cells and a biochip for implementation of the diagnosis
Application Number
EP20040011015 20040507
Publication Number
1593385(A1)
Application Date
May 7, 2004
Publication Date
November 9, 2005
Inventor
Class Reiner Dr Ph D
DE
Assignee
Educatio
US
Philadelphia Health &Amp
Symbiotec
DE
IPC
C12Q 01/68
A61P 31/12
A61K 38/16
G01N 33/68
G01N 33/569
C12Q 01/68
A61K 38/17
A61K 38/16
G01N 33/68
G01N 33/569
C12Q 01/68
A61K 38/17
A61K 38/16
View Original Source Download PDF